Organic Process Research & Development 2006, 10, 599−604
Optimizing Fermentation Conditions of Recombinant Escherichia coli
Expressing Cyclopentanone Monooxygenase
Florian Rudroff,† Ve´ronique Alphand,‡ Roland Furstoss,‡ and Marko D. Mihovilovic*,†
Vienna UniVersity of Technology, Institute of Applied Synthetic Chemistry, Getreidemarkt 9/163-OC,
A-1060 Vienna, Austria, and Groupe Biocatalyse et Chimie Fine, UMR CNRS 6111, UniVersite´ de la Me´diterrane´e,
Faculte´ des Sciences de Luminy, Case 901, 163 aVenue de Luminy, 13288 Marseille Cedex 9, France
Abstract:
Microbial Baeyer-Villiger oxidation of different substrates with
cyclopentanone monooxygenase (CPMO) from Comamonas
NCIMB 9872 was up-scaled to benchtop fermenter scale.
Conditions for cell growth and biocatalyst production were
optimized, and a convenient, environmentally friendly and
Figure 1. Baeyer-Villiger oxidation of cyclic ketones to
applicable methodology for the preparation of chiral building
blocks for natural product and bioactive compound synthesis
was developed by applying a resin based on the concept of in
situ “substrate feeding-product removal” (SFPR). Three dif-
ferent ketones (4-methylcyclohexanone, rac-3-methylcyclohex-
anone, and 8-oxabicyclo[3.2.1]oct-6-en-3-one) were converted
in 5-15 g/L scale in a conventional bioreactor, with a volu-
metric productivity of up to 1 g L-1 h-1 in good to excellent
yield and enantiomeric purity.
lactones.
of this reaction, which require potentially explosive oxidants
(such as hydrogen peroxide or various peracids), display
limited functional group tolerance, and lack high stereo-
selectivity with de novo designed chiral catalysts, biocatalysis
offers a very mild, environmental friendly and stereoselective
entry to this process by utilizing molecular oxygen as
oxidant.6 An increasing number of flavin-dependent Baeyer-
Villiger monooxygenases (BVMOs) with a remarkably broad
profile of non-natural substrates has been identified during
recent years.7,8 This led to the identification of an increasing
variety of structurally diverse substrate ketones which are
converted efficiently and in high stereoselectivity and which
can serve as precursors for the subsequent asymmetric
synthesis of natural and bioactive compounds (Figure 2).9
Consequently, the development of an applicable and efficient
up-scaling process to overcome limitations in accessibility
of such chiral intermediates is becoming increasingly im-
portant to the field.10
Introduction
As biocatalysis moves from laboratory to production
scales, economic considerations become increasingly im-
portant.1 High stereoselectivity and good substrate acceptance
can be achieved by choosing the most appropriate enzyme.
Suitable biocatalysts can be obtained by screening recom-
binant whole cells or isolated enzymes from the natural
diversity.2 In addition, modern molecular biological meth-
odologies such as directed evolution or gene shuffling offer
strategies to influence and optimize the performance of a
biocatalytic entity.3
Enzyme-mediated Baeyer-Villiger oxidation offers a
“green chemistry” approach for the production of chiral
lactones.4 This reaction (Figure 1), named after its discoverers
Adolf von Baeyer and Victor Villiger, represents a powerful
methodology in synthesis for breaking carbon-carbon bonds
in oxygen-insertion process.5 In contrast to classical protocols
(5) Baeyer, A.; Villiger, V. Chem. Ber. 1899, 32, 3625.
(6) Mihovilovic, M. D.; Rudroff, F.; Gro¨tzl, B. Curr. Org. Chem. 2004, 8, 1057.
(7) (a) Roberts, S. M.; Wan, P. W. H. J. Mol. Catal. B: Enzym. 1998, 4, 111.
(b) Kamerbeek, N. M.; Janssen, D. B.; van Berkel, W. J. H.; Fraaije, M.
W. AdV. Synth. Catal. 2003, 345, 667.
(8) (a) Donoghue, N. A.; Norris, D. B.; Trudgill, P. W. Eur. J. Biochem. 1976,
63, 175. (b) Griffin, M.; Trudgill, P. W. Eur. J. Biochem. 1976, 63, 199.
(c) Brzostowicz, P. C.; Gibson, K. L.; Thomas, S. M.; Blasko, M. S.;
Rouviere, P. E. J. Bacteriol. 2000, 182, 4241. (d) Brzostowicz, P.; Walters,
D. M.; Thomas, S. M.; Nagarajan, V.; Rouviere, P. E. Appl. EnViron.
Microbiol. 2003, 69, 334. (d) Fraaije, M. W.; Kamerbeek, N. M.; van Berkel,
W. J. H.; Janssen, D. B. FEBS Lett. 2002, 518, 43. (e) Fraaije M. W.;
Kamerbeek, N. M.; Heidekamp, A. J.; Fortin, R.; Janssen, D. B. J. Biol.
Chem. 2004, 279, 3354. (f) Reetz, M. T.; Brunner, B.; Schneider, T.; Schulz,
F.; Clouthier, C. M.; Kayser, M. M. Angew. Chem., Int. Ed. 2004, 43, 4075.
(g) Bocola, M.; Schulz, F.; Leca, F.; Vogel, A.; Fraaije, M. W.; Reetz, M.
T. AdV. Synth. Catal. 2005, 347, 979. (h) Fraaije, M. W.; Wu, J.; Heuts, D.
P. H. M.; van Hellemond, E. W.; Spelberg, J. H. L.; Janssen, D. B. Appl.
Microbiol. Biotechnol. 2005, 66, 393. (i) Luna, A.; Gutierrez, M.-C.;
Furstoss, R.; Alphand, V. Tetrahedron Asymmetry 2005, 16, 2521.
(9) (a) Iwaki, H.; Hasegawa, Y.; Lau, P. C. K.; Wang, S.; Kayser, M. M. Appl.
EnViron. Microbiol. 2002, 68, 5671. (b) Mihovilovic, M. D.; Mu¨ller, B.;
Kayser, M. M.; Stewart, J. D.; Stanetty, P. Synlett 2002, 700. (c)
Mihovilovic, M. D.; Mu¨ller, B.; Schulze, A.; Stanetty, P.; Kayser, M. M.
Eur. J. Org. Chem. 2003, 2243. (d) Mihovilovic, M. D.; Rudroff, F.; Gro¨tzl,
B.; Stanetty, P. Eur. J. Org. Chem. 2005, 5, 809.
* To whom correspondence should be addressed. E-mail: mmihovil@
pop.tuwien.ac.at. Telephone: +43-1-58801-15420. Fax: +43-1-58801-15499.
† Vienna University of Technology, Institute of Applied Synthetic Chemistry.
‡ Universite´ de la Me´diterrane´e, Faculte´ des Sciences de Luminy.
(1) (a) Wandrey, C.; Liese, A.; Kihumbu, D. Org. Process Res. DeV. 2000, 4,
286. (b) Schmid, A.; Dordick, J. S.; Hauer, B.; Kiener, A.; Wubbolts, M.;
Withold, B. Nature 2001, 409, 258. (c) Straathof, A. J. J.; Panke, S.; Schmid,
A. Curr. Opin. Biotechnol. 2002, 13, 548.
(2) Demirjian, D. C.; Shah, P. C.; Mor´ıs-Varas, F. Top. Curr. Chem. 1999,
200, 1.
(3) (a) Huisman, G. W.; Gray, D. Curr. Opin. Biotechnol. 2002, 13, 352. (b)
Zhao, H.; Chockalingam, K.; Chen, Z. Curr. Opin. Biotechnol. 2002, 13,
104.
(4) (a) Krow, G. R. Org. React. 1993, 43, 251. (b) Renz, M.; Meunier, B. Eur.
J. Org. Chem. 1999, 737. (c) Mihovilovic, M. D.; Mu¨ller, B.; Stanetty, P.
Eur. J. Org. Chem. 2002, 3711.
(10) Alphand, V.; Carrea, G.; Wohlgemuth, R.; Furstoss, R.; Woodley J. M.
Trends Biotechnol. 2003, 21, 318.
10.1021/op0502654 CCC: $33.50 © 2006 American Chemical Society
Published on Web 03/07/2006
Vol. 10, No. 3, 2006 / Organic Process Research & Development
•
599